Circulating miR-30 is related to carotid artery atherosclerosis
Yuqing Huang1, Jiyan Chen1, Yingling Zhou1
1a Department of Cardiology , Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology , Guangzhou , China.
Insights
Lower levels of miR-30 were found in hypertensive patients and those with increased carotid intima-media thickness (CIMT). This suggests miR-30 may serve as a biomarker for atherosclerosis in hypertension.
Area of Science:
- Cardiovascular Disease Research
- Molecular Biology
- Biomarker Discovery
Background:
- Hypertension is a major risk factor for cardiovascular diseases, including atherosclerosis.
- Carotid intima-media thickness (CIMT) is a marker of subclinical atherosclerosis.
- MicroRNAs (miRNAs) are implicated in the pathogenesis of cardiovascular diseases.
Purpose of the Study:
- To investigate the association between miR-30 expression and blood pressure parameters.
- To evaluate the relationship of miR-30 with carotid intima-media thickness (CIMT).
- To determine if miR-30 can serve as a biomarker for atherosclerosis in hypertensive patients.
Main Methods:
- Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to measure miR-30 expression in 40 hypertensive patients and 40 controls.
- Carotid artery ultrasonography to assess CIMT.
- Office and ambulatory blood pressure monitoring.
- Spearman correlation and logistic regression analyses to assess associations.
Main Results:
- Hypertensive patients exhibited significantly lower miR-30 expression compared to healthy controls.
- Lower miR-30 levels were also observed in individuals with increased CIMT.
- miR-30 expression showed a significant negative correlation with 24-hour systolic blood pressure, 24-hour diastolic blood pressure, office systolic blood pressure, and CIMT.
Conclusions:
- Circulating miR-30 levels are reduced in patients with essential hypertension and atherosclerosis.
- miR-30 may function as a potential biomarker for identifying atherosclerosis in individuals with hypertension.
Objectives:
The aim of this study is to evaluate the relationship of miR-30 with office and ambulatory blood pressure parameters and carotid intima-media thickness (CIMT) in patients with hypertension and healthy controls.
Methods:
We assessed the expression level of miR-30 in 40 patients with essential hypertension and 40 healthy individuals. All patients underwent carotid artery ultrasonography, and office and ambulatory blood pressure monitoring. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was used to evaluate the expression level of selected miR-30. The miR-30 expression level correlation between blood pressure parameters and CIMT was assessed using the Spearman correlation coefficient. Multiple logistic regression analysis was performed to assess independent association between miR-30 expression level and CIMT.
Results:
We observed lower expression level of miR-30 (26.01 ± 2.40 vs. 28.26 ± 1.28; p < 0.001) in hypertensive patients compared with healthy control individuals, as well as in increased CIMT group compared with normal CIMT group (25.09 ± 1.84 vs. 27.81 ± 2.37; p < 0.001). miR-30 expression level showed significant negative correlation with 24 h mean SBP (r = -0.51, p < 0.001), 24 h mean DBP(r = -0.316, p = 0.004), office SBP(r = -0.502, p < 0.001), office DBP (r = -0.205, p = 0.068), and CIMT (r = -0.578, p < 0.001), respectively. The odds ratio for CIMT was 0.519 (B = -0.748, CI 95% 0.278, 0.806; p = 0.006).
Conclusion:
Our study suggests that circulating miR-30 might be used as a biomarker for atherosclerosis in essential hypertensive patients.
More Related Videos
09:33A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
